H. Lundbeck A/S (HLUN-B.CO) stock analysis

In our weekly check, H. Lundbeck A/S is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 23 pass, warnings: 1, red flags: 1.

About H. Lundbeck A/S

H. Lundbeck A/S is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Denmark, listed on CPH as HLUN-B.CO.

What our checks show for HLUN-B.CO

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-10

Similar companies

GALD.SW · TEVA · HLN

Questions

What grade does H. Lundbeck A/S (HLUN-B.CO) have?

In our weekly check, H. Lundbeck A/S is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 23 pass, warnings: 1, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of HLUN-B.CO stock?

This week's biggest flags for H. Lundbeck A/S: Weak revenue forecast, Deep past fall. In total 2 of 25 checks show a warning or a red flag.

What does H. Lundbeck A/S do?

H. Lundbeck A/S is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Denmark, listed on CPH as HLUN-B.CO.

When does H. Lundbeck A/S report earnings next?

The next earnings report is expected on 2027-02-10. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis